These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 18000182

  • 1. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.
    Jani R, Molina M, Matsuda M, Balas B, Chavez A, DeFronzo RA, Abdul-Ghani M.
    Diabetes Care; 2008 Feb; 31(2):311-5. PubMed ID: 18000182
    [Abstract] [Full Text] [Related]

  • 2. Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects.
    Abdul-Ghani MA, Matsuda M, DeFronzo RA.
    Diabet Med; 2008 Nov; 25(11):1289-94. PubMed ID: 19046218
    [Abstract] [Full Text] [Related]

  • 3. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [Abstract] [Full Text] [Related]

  • 4. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [Abstract] [Full Text] [Related]

  • 5. Effect of liver fat on insulin clearance.
    Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H.
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1709-15. PubMed ID: 17895288
    [Abstract] [Full Text] [Related]

  • 6. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
    DeFronzo RA, Simonson DC.
    Diabetes Care; 1984 Dec; 7 Suppl 1():72-80. PubMed ID: 6428844
    [Abstract] [Full Text] [Related]

  • 7. A study to evaluate surrogate markers of insulin resistance in forty euglycemic healthy subjects.
    Gupta AK, Jain SK.
    J Assoc Physicians India; 2004 Jul; 52():549-53. PubMed ID: 15645980
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA.
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [Abstract] [Full Text] [Related]

  • 9. [Hepatic and peripheral insulin resistance as a cause of hyperglycemia in non-insulin-dependent (type 2) diabetes mellitus: a review].
    Bratusch-Marrain P, Waldhäusl W.
    Wien Klin Wochenschr; 1987 Apr 03; 99(7):211-6. PubMed ID: 3296467
    [Abstract] [Full Text] [Related]

  • 10. In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance.
    Haugaard SB, Andersen O, Hansen BR, Andersen UB, Vølund A, Iversen J, Nielsen JO, Madsbad S.
    Metabolism; 2005 Feb 03; 54(2):171-9. PubMed ID: 15690310
    [Abstract] [Full Text] [Related]

  • 11. Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices.
    García-Estévez DA, Araújo-Vilar D, Fiestras-Janeiro G, Saavedra-González A, Cabezas-Cerrato J.
    Horm Metab Res; 2003 Jan 03; 35(1):13-7. PubMed ID: 12669265
    [Abstract] [Full Text] [Related]

  • 12. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.
    Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA.
    Diabetes Care; 2007 Jan 03; 30(1):89-94. PubMed ID: 17192339
    [Abstract] [Full Text] [Related]

  • 13. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
    Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P, Bischof MG, Wolzt M, Ludvik B, Kästenbauer T, Pacini G, Luger A, Krebs M.
    Diabetes Care; 2007 Sep 03; 30(9):2374-80. PubMed ID: 17595351
    [Abstract] [Full Text] [Related]

  • 14. The effect of pioglitazone on the liver: role of adiponectin.
    Gastaldelli A, Miyazaki Y, Mahankali A, Berria R, Pettiti M, Buzzigoli E, Ferrannini E, DeFronzo RA.
    Diabetes Care; 2006 Oct 03; 29(10):2275-81. PubMed ID: 17003306
    [Abstract] [Full Text] [Related]

  • 15. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
    Mayorov AY, Naumenkova IV, Antsiferov MB, Dedov II.
    Diabetes Res Clin Pract; 2005 Jun 03; 68 Suppl1():S54-9. PubMed ID: 15955377
    [Abstract] [Full Text] [Related]

  • 16. Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database.
    Sesti G, Andreozzi F, Bonadonna RC, De Mattia G, Leonetti F, Luzi L, Marini MA, Natali A, Vettor R, Bonora E, Group of Italian Scientists of Insulin Resistance (GISIR).
    Diabetes Metab Res Rev; 2008 Feb 03; 24(2):130-6. PubMed ID: 17922529
    [Abstract] [Full Text] [Related]

  • 17. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T, Lockton JA, Renstrom F, Lystig T, Sukonina V, Svensson MK, Eriksson JW.
    Metabolism; 2009 Jun 03; 58(6):860-6. PubMed ID: 19375766
    [Abstract] [Full Text] [Related]

  • 18. Production and metabolic clearance of glucose under basal conditions in Type II (non-insulin-dependent) diabetes mellitus.
    Radziuk J, Pye S.
    Diabetologia; 2001 Aug 03; 44(8):983-91. PubMed ID: 11484075
    [Abstract] [Full Text] [Related]

  • 19. The effect of body mass index on fasting blood glucose and development of diabetes mellitus after initiation of extended-release niacin.
    Libby A, Meier J, Lopez J, Swislocki AL, Siegel D.
    Metab Syndr Relat Disord; 2010 Feb 03; 8(1):79-84. PubMed ID: 19943800
    [Abstract] [Full Text] [Related]

  • 20. Relation of plasma obestatin levels to bmi, gender, age and insulin.
    Lippl F, Erdmann J, Lichter N, Tholl S, Wagenpfeil S, Adam O, Schusdziarra V.
    Horm Metab Res; 2008 Nov 03; 40(11):806-12. PubMed ID: 18622896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.